Promega Corporation

Multiplexed Viability Cytotoxicity And Apoptosis Assays For Cell-Based Screening

  • Share
  • Print
  • Email
  • Download PDF
  • Article
  • Comments & Ratings

Abstract

Previously, we introduced the MultiTox-Fluor Multiplex Cytotoxicity Assay technology as a novel means for determining the relative number of live and dead cells in culture. In this article, we demonstrate that the assay technology is sufficiently scalable, sensitive and robust to be multiplexed with other downstream assays to increase the quality of screening data.

Cell Notes 16, 12–15.

Andrew Niles1, Tracy Worzella1, Michael Scurria2, William Daily2, Laurent Bernad2, Pam Guthmiller1, Brian McNamara1, Kay Rashka1, Deborah Lagne1, and Terry L. Riss1

1Promega Corporation, 2Promega Biosciences, Inc.
Publication Date: 2006

Download Article (225 KB)

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.

Click Here for Technical Questions and Ordering Support »